DK1126846T3 - Anvendelse af en nikotinreceptoragonist til behandling af tvangsneuroser i form af obsessiv kompulsiv tilstand - Google Patents
Anvendelse af en nikotinreceptoragonist til behandling af tvangsneuroser i form af obsessiv kompulsiv tilstandInfo
- Publication number
- DK1126846T3 DK1126846T3 DK99957446T DK99957446T DK1126846T3 DK 1126846 T3 DK1126846 T3 DK 1126846T3 DK 99957446 T DK99957446 T DK 99957446T DK 99957446 T DK99957446 T DK 99957446T DK 1126846 T3 DK1126846 T3 DK 1126846T3
- Authority
- DK
- Denmark
- Prior art keywords
- obsessive compulsive
- treatment
- receptor agonist
- nicotine receptor
- compulsive disorder
- Prior art date
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title abstract 3
- 229960002715 nicotine Drugs 0.000 title abstract 3
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title abstract 3
- 239000000018 receptor agonist Substances 0.000 title abstract 3
- 229940044601 receptor agonist Drugs 0.000 title abstract 3
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803732A SE9803732D0 (sv) | 1998-11-02 | 1998-11-02 | Nicotine treatment for obsessive compulsive disorder |
| PCT/SE1999/001948 WO2000025783A1 (en) | 1998-11-02 | 1999-10-29 | Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1126846T3 true DK1126846T3 (da) | 2003-09-29 |
Family
ID=20413142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99957446T DK1126846T3 (da) | 1998-11-02 | 1999-10-29 | Anvendelse af en nikotinreceptoragonist til behandling af tvangsneuroser i form af obsessiv kompulsiv tilstand |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1126846B1 (da) |
| JP (1) | JP2002528501A (da) |
| AT (1) | ATE246503T1 (da) |
| AU (1) | AU1514700A (da) |
| CA (1) | CA2347855A1 (da) |
| DE (1) | DE69910242T2 (da) |
| DK (1) | DK1126846T3 (da) |
| ES (1) | ES2203210T3 (da) |
| NZ (1) | NZ511226A (da) |
| PT (1) | PT1126846E (da) |
| SE (1) | SE9803732D0 (da) |
| WO (1) | WO2000025783A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL137937A0 (en) * | 1999-08-27 | 2001-10-31 | Pfizer Prod Inc | A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
| EP1358177B1 (en) | 2000-10-13 | 2006-08-02 | NeuroSearch A/S | Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| DE20018196U1 (de) | 2000-10-25 | 2001-01-11 | Peter, Michael N., 22297 Hamburg | Erzeugnis aus Zuckerware für Raucherentwöhnung |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776956A (en) * | 1996-07-30 | 1998-07-07 | Lectec Corporation | Use of cotinine in treating psychiatric disorders |
-
1998
- 1998-11-02 SE SE9803732A patent/SE9803732D0/xx unknown
-
1999
- 1999-10-29 DK DK99957446T patent/DK1126846T3/da active
- 1999-10-29 NZ NZ511226A patent/NZ511226A/xx unknown
- 1999-10-29 AU AU15147/00A patent/AU1514700A/en not_active Abandoned
- 1999-10-29 WO PCT/SE1999/001948 patent/WO2000025783A1/en not_active Ceased
- 1999-10-29 DE DE69910242T patent/DE69910242T2/de not_active Expired - Fee Related
- 1999-10-29 AT AT99957446T patent/ATE246503T1/de not_active IP Right Cessation
- 1999-10-29 PT PT99957446T patent/PT1126846E/pt unknown
- 1999-10-29 ES ES99957446T patent/ES2203210T3/es not_active Expired - Lifetime
- 1999-10-29 CA CA002347855A patent/CA2347855A1/en not_active Abandoned
- 1999-10-29 EP EP99957446A patent/EP1126846B1/en not_active Expired - Lifetime
- 1999-10-29 JP JP2000579224A patent/JP2002528501A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2347855A1 (en) | 2000-05-11 |
| SE9803732D0 (sv) | 1998-11-02 |
| NZ511226A (en) | 2003-01-31 |
| EP1126846A1 (en) | 2001-08-29 |
| PT1126846E (pt) | 2003-12-31 |
| ATE246503T1 (de) | 2003-08-15 |
| DE69910242T2 (de) | 2004-06-17 |
| AU1514700A (en) | 2000-05-22 |
| WO2000025783A1 (en) | 2000-05-11 |
| JP2002528501A (ja) | 2002-09-03 |
| ES2203210T3 (es) | 2004-04-01 |
| DE69910242D1 (de) | 2003-09-11 |
| EP1126846B1 (en) | 2003-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0867178T3 (da) | Non-allosteriske GABA A agonister til behandling af søvnforstyrrelser | |
| AU4818000A (en) | Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands | |
| WO2001001973A3 (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same | |
| BR0210855A (pt) | Método de fabricação de formulações de liberação prolongada | |
| WO2001087328A3 (en) | Interleukin-1 inhibitors in the treatment of diseases | |
| BR0206568A (pt) | Novo método e composições para o tratamento local de doença de meniere, de zumbido no ouvido e/ou de perda de audição | |
| NO20015413L (no) | Anvendelse av dopamin-D3-reseptor-ligander for fremstilling av medikamenter for behandling av nyrefunksjonsforstyrrelser | |
| EE200200107A (et) | Kiire algtoimega selektiivse serotoniini tagasihaaramise inhibiitori kasutamine ravimi valmistamiseks, mis on ette nähtud seksuaalse funktsioonihäireravimiseks | |
| EP1440689A3 (en) | Treatment of neurotic disorders | |
| SE9902267D0 (sv) | New compounds | |
| NO20013414L (no) | Ny anvendelse av melagatran | |
| DK0966285T3 (da) | Anvendelse af (+)mefloquin til behandling af malaria | |
| NO20031410L (no) | Anvendelse av distamycinderivater for fremstilling av medikamenter | |
| NO20042758L (no) | Fremgangsmate for behandling av en pasient som krever analgesi. | |
| DE69917005D1 (de) | Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung | |
| SE9902597D0 (sv) | New use | |
| SE9803732D0 (sv) | Nicotine treatment for obsessive compulsive disorder | |
| TNSN99158A1 (ar) | طريقة لمنع الاصابة بالربو | |
| TR200100670T2 (tr) | R(+)-alfa-(2,3-Dimetoksifenil)-1- [2-(4-florofenil)etil]-4-piperidinmetanol' ün uyku düzensizlikleri tedavisinde kullanımı. | |
| EE200100193A (et) | 3-(1H-imidasool-4-ülmetüül)-indaan-5-ol'i kasutamine intraspinaalselt, teekasiseselt või epiduraalselt manustatava ravimi tootmises | |
| NO984196L (no) | FremgangsmÕte for behandling av stoffmisbruk | |
| SE0102888D0 (sv) | New formulation | |
| WO2005049024A3 (de) | Feste pharmazeutische zubereitungsform | |
| MX2008000780A (es) | Combinacion terapeutica que comprende un bloqueador de receptores nmda y una sustancia narcotica analgesica. | |
| CA2532330A1 (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same |